Goodman Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$423K Hold
460
0.11% 68
2025
Q4
$494K Hold
460
0.12% 56
2025
Q3
$351K Hold
460
0.09% 59
2025
Q2
$359K Hold
460
0.12% 48
2025
Q1
$380K Buy
+460
New +$383K 0.12% 66
2024
Q4
Sell
-460
Closed -$408K 123
2024
Q3
$408K Hold
460
0.12% 65
2024
Q2
$416K Sell
460
-352
-43% -$282K 0.12% 65
2024
Q1
$632K Buy
812
+352
+77% +$251K 0.2% 58
2023
Q4
$268K Hold
460
0.09% 62
2023
Q3
$247K Hold
460
0.09% 63
2023
Q2
$216K Hold
460
0.08% 57
2023
Q1
$158K Hold
460
0.09% 53
2022
Q4
$168K Hold
460
0.1% 50
2022
Q3
$149K Hold
460
0.08% 54
2022
Q2
$149K Buy
+460
New +$138K 0.07% 53

Other funds holding LLY

Goodman Advisory Group's LLY Position: Q1 2026 in Review

Goodman Advisory Group held its Eli Lilly (LLY) position steady in Q1 2026 at 460 shares worth $423K. The position accounts for 0.11% of the portfolio, ranked #68.

Goodman Advisory Group first reported a position in LLY in Q2 2022 and has held it in 15 quarters since. The position peaked at $632K in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Goodman Advisory Group held 460 shares of Eli Lilly worth $423K as of Q1 2026.
  • Goodman Advisory Group left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.11% of Goodman Advisory Group's portfolio in Q1 2026, its #68 holding.
  • Goodman Advisory Group first reported a position in Eli Lilly in Q2 2022 and has held it in 15 quarters since.
  • Goodman Advisory Group's Eli Lilly position peaked at $632K in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Goodman Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.